These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25498086)

  • 1. Risk factors of cytomegalovirus infection after pediatric liver transplantation.
    Kawano Y; Mizuta K; Sanada Y; Urahashi T; Ihara Y; Okada N; Yamada N; Sasanuma H; Sakuma Y; Taniai N; Yoshida H; Kawarasaki H; Yasuda Y; Uchida E
    Transplant Proc; 2014 Dec; 46(10):3543-7. PubMed ID: 25498086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
    Wadhawan M; Gupta S; Goyal N; Vasudevan KR; Makki K; Dawar R; Sardana R; Lal N; Kumar A
    Liver Transpl; 2012 Dec; 18(12):1448-55. PubMed ID: 22903934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus infection in living related liver transplantation: rapid diagnosis by human monoclonal antibody staining of blood leucocytes.
    Sano K; Tanaka K; Uemoto S; Fujita S; Tokunaga Y; Inomata Y; Ozawa K; Minamishima Y
    Transplant Sci; 1994 Sep; 4(1):105-11. PubMed ID: 7528626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of cytomegalovirus infection after living donor liver transplantation.
    Akamatsu N; Sugawara Y; Kaneko J; Kishi Y; Makuuchi M
    Hepatogastroenterology; 2005; 52(61):197-9. PubMed ID: 15783029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus infection in living-donor and cadaveric lung transplantations.
    Ohata K; Chen-Yoshikawa TF; Takahashi K; Aoyama A; Motoyama H; Hijiya K; Hamaji M; Menju T; Sato T; Sonobe M; Takakura S; Date H
    Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):710-715. PubMed ID: 29049752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infection in living donor liver transplant recipients significantly impacts the early post-transplant outcome: A single center experience.
    Yadav SK; Saigal S; Choudhary NS; Saha S; Sah JK; Saraf N; Kumar N; Goja S; Rastogi A; Bhangui P; Soin AS
    Transpl Infect Dis; 2018 Aug; 20(4):e12905. PubMed ID: 29668120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fulminant Hepatic Failure as a Risk Factor for Cytomegalovirus Infection in Children Receiving Preemptive Therapy After Living Donor Liver Transplantation.
    Furuichi M; Fujiwara T; Fukuda A; Kasahara M; Miyairi I
    Transplantation; 2016 Nov; 100(11):2404-2409. PubMed ID: 27495753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors.
    Shah T; Lai WK; Mutimer D
    Transpl Infect Dis; 2005 Jun; 7(2):57-62. PubMed ID: 16150091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast patterns of Cytomegalovirus and Epstein-Barr virus infection in pediatric living-donor liver transplant recipients.
    Nafady-Hego H; Elgendy H; Uemoto S
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():75-82. PubMed ID: 25894132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of cytomegalovirus and human herpesvirus-6 DNA in liver biopsy specimens and their correlation with rejection after liver transplantation.
    Guardia-Silva AC; Stucchi RS; Sampaio AM; Milan A; Costa SC; Boin IF
    Transplant Proc; 2012 Oct; 44(8):2441-4. PubMed ID: 23026615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia.
    Kim JM; Lee SK; Kim SJ; Joh JW; Kwon CH; Choe YH; Shin M; Kim EY; Moon JI; Jung GO; Choi GS
    Transplant Proc; 2010 Apr; 42(3):895-9. PubMed ID: 20430199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
    Jain A; Orloff M; Kashyap R; Lansing K; Betts R; Mohanka R; Menegus M; Ryan C; Bozorgzadeh A
    Transplant Proc; 2005 Sep; 37(7):3182-6. PubMed ID: 16213344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan.
    Kanda Y; Mineishi S; Saito T; Seo S; Saito A; Suenaga K; Ohnishi M; Niiya H; Nakai K; Takeuchi T; Kawahigashi N; Shoji N; Ogasawara T; Tanosaki R; Kobayashi Y; Tobinai K; Kami M; Mori S; Suzuki R; Kunitoh H; Takaue Y
    Bone Marrow Transplant; 2001 Feb; 27(4):437-44. PubMed ID: 11313674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation.
    Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of donor-recipient cytomegalovirus serology on adult liver transplantation: a single center experience.
    Tryphonopoulos P; Weppler D; Morris MI; Russo C; Nishida S; Levi DM; Moon J; Tekin A; Selvaggi G; Island E; Arosemena L; Ruiz P; Tzakis AG
    Transplantation; 2011 Nov; 92(9):1051-7. PubMed ID: 21876474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with the development of cytomegalovirus infection following solid organ transplantation.
    da Cunha-Bang C; Sørensen SS; Iversen M; Sengeløv H; Hillingsø JG; Rasmussen A; Mortensen SA; Fox ZV; Kirkby NS; Christiansen CB; Lundgren JD
    Scand J Infect Dis; 2011 May; 43(5):360-5. PubMed ID: 21306196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
    Seehofer D; Rayes N; Tullius SG; Schmidt CA; Neumann UP; Radke C; Settmacher U; Müller AR; Steinmüller T; Neuhaus P
    Liver Transpl; 2002 Dec; 8(12):1138-46. PubMed ID: 12474153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes.
    Al-Hajjar S; Al Seraihi A; Al Muhsen S; Ayas M; Al Jumaah S; Al Jefri A; Shoukri M; El Solh H
    Hematol Oncol Stem Cell Ther; 2011; 4(2):67-72. PubMed ID: 21727767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMV Primary Infection Is Associated With Donor-Specific T Cell Hyporesponsiveness and Fewer Late Acute Rejections After Liver Transplantation.
    Shi XL; de Mare-Bredemeijer EL; Tapirdamaz Ö; Hansen BE; van Gent R; van Campenhout MJ; Mancham S; Litjens NH; Betjes MG; van der Eijk AA; Xia Q; van der Laan LJ; de Jonge J; Metselaar HJ; Kwekkeboom J
    Am J Transplant; 2015 Sep; 15(9):2431-42. PubMed ID: 25943855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of cytomegalovirus infection after living donor liver transplantation.
    Yamanouchi K; Eguchi S; Takatsuki M; Kamohara Y; Hidaka M; Miyazaki K; Inokuma T; Tajima Y; Kanematsu T
    Hepatogastroenterology; 2012; 59(113):231-4. PubMed ID: 22251542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.